使用集成的计算和生物化学方法研究草药化合物的Sortase A抑制潜力
Akanksha Haldiya1, Himanshi Kain1, Saumya Dubey2
1Amity Institute of Biotechnology, Amity University Rajasthan, Jaipur, Rajasthan 303002, India.
Acta tropica
|October 16, 2024
概括
天然化合物鲁丁三水合物和奎尔素抑制Sortase A (EfSrtAΔN59) 并减少Enterococcus faecalis中的生物膜形成. 这些发现为针对耐药细菌的新抗病毒疗法提供了潜力.
科学领域:
- 微生物学 微生物学
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 多种耐药细菌对全球健康构成重大威胁,需要新的治疗策略.
- 排列酶A (EfSrtAΔN59) 是Enterococcus faecalis中的关键毒性因子,对粘附和生物膜形成至关重要.
- 针对EfSrtAΔN59提供了一种有希望的方法来对抗持久的E. faecalis感染.
研究的目的:
- 调查鲁三水和奎尔对EfSrtAΔN59活性的抑制作用.
- 评估这些黄素对E. faecalis生物膜形成的影响.
- 探索这些天然化合物作为抗病毒剂的潜力.
主要方法:
- 在体外酶分析测量以测量EfSrtAΔN59的抑制.
- 生物膜量化技术用于评估细菌生长.
- 分子对接和分子动力学 (MD) 模拟来分析化合物-酶相互作用.
主要成果:
- 鲁丁三水合物和奎尔素都显著抑制了EfSrtAΔN59的活性.
- 这些黄类药物显著降低了E. faecalis生物膜生物量.
- 分子研究证实了这些化合物与EfSrtAΔN59.59.之间强烈的结合亲和关系.
结论:
- 鲁丁三水合物和奎尔丁显示出对EfSrtAΔN59和E. faecalis生物膜的强有力的抑制作用.
- 这些天然化合物显示出作为新型抗病毒剂的前景.
- 它们代表了传统抗生素治疗E. faecalis感染的潜在替代品.
更多相关视频
08:20Systematic Approach to Identify Novel Antimicrobial and Antibiofilm Molecules from Plants' Extracts and Fractions to Prevent Dental Caries
Published on: March 31, 2021
6.3K
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
13.6K
相关概念视频
01:28Structure-Activity Relationships and Drug Design
668
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
668
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
534
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
534